Canadian based Renaissance BioScience Corp., a leading global bioengineering company, is pleased to announce that it has recently received new patent allowances and grants for its non-GMO acrylamide-reducing yeast (ARY) from regulatory authorities in China, Russia, India, Australia and Vietnam. These five new ARY patent grants and allowances join previously issued patents from the U.S., Japan, Indonesia, Chile and Colombia, with patents pending in multiple additional markets.
Renaissance BioScience CEO and CSO, Dr. John Husnik, commented on the newly granted patents: “As an intellectual property-focused company we are pleased to receive the new patent grants and allowances in the major markets of China, Russia, India, Australia and Vietnam. These new patents join those already granted or pending in other major markets around the world, to protect the use of our acrylamide-reducing yeast in many different and important food manufacturing applications.”
He added, “Acrylamide is a carcinogen of global concern – especially for children, who tend to consume more than adults due to their daily diet of many common foods that unfortunately contain this carcinogen (potato chips, crackers, bread, cookies, cereals and the like).
“We are especially pleased that our acrylamide-reducing yeast is finding acceptance and being commercialized by food manufacturers in markets all around the world with a mandate to reduce the presence of this contaminant in their products.”
Based in Vancouver, Canada, Renaissance is an environmental impact company whose bioengineering platform technologies are used to develop innovative, market-ready, functional microorganisms that provide solutions to a broad range of health, environmental and industrial problems. Detailed information about the Renaissance group of companies is available at www.renaissancebioscience.com.
Source: Renaissance BioScience Corp.
Cover image: Courtesy Thermo Fisher
Further information:
Steve Campbell
Campbell & Company Strategies Inc.
Vancouver, BC, Canada
01 604 888-5267
renaissance@ccom-pr.com
For commercial or technology development inquiries:
Dr. John Husnik, CEO
Renaissance BioScience Corp.
Vancouver, BC, Canada
01 604 822-6499
info@renaissancebioscience.com
